Beyond proteolysis-targeting chimeric molecules: designing heterobifunctional molecules based on functional effectors
L Hua, Q Zhang, X Zhu, R Wang, Q You… - Journal of Medicinal …, 2022 - ACS Publications
In recent years, with the successful development of proteolysis-targeting chimeric molecules
(PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug …
(PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug …
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors
L Hua, Q Zhang, X Zhu, R Wang… - Journal of medicinal …, 2022 - pubmed.ncbi.nlm.nih.gov
In recent years, with the successful development of proteolysis-targeting chimeric molecules
(PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug …
(PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug …
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors.
L Hua, Q Zhang, X Zhu, R Wang, Q You… - Journal of Medicinal …, 2022 - europepmc.org
In recent years, with the successful development of proteolysis-targeting chimeric molecules
(PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug …
(PROTACs), the potential of heterobifunctional molecules to contribute to reenvisioning drug …